FDA 503B outsourcing facilities in Massachusetts
Massachusetts has 1 FDA-registered 503B outsourcing facility in the PeptideGrids directory, none with FDA drug recalls on record, the earliest registered in 2017. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Fresenius Kabi Compounding LLC dba Fagron Sterile Services | Canton | 2017 | None on record |
503B compounding in Massachusetts
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Massachusetts must hold the appropriate state pharmacy license. Verify any facility's current license with the Massachusetts Board of Registration in Pharmacy.
Compounded peptides and GLP-1s
503B facilities are a primary supply route for compounded peptides and GLP-1s, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the full GLP-1 and therapeutic peptide databases, or the national directory.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Massachusetts?
1 FDA-registered 503B outsourcing facility is listed in Massachusetts on PeptideGrids, the earliest registered in 2017.
Which Massachusetts 503B facilities have FDA recalls on record?
None of the Massachusetts facilities in our directory have FDA drug recalls on record.
How do I verify a pharmacy license in Massachusetts?
Use the Massachusetts Board of Registration in Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.